Welcome to the 13th International Congress on Autoimmunity interactive program

45 Sessions

Sort By Session Date
Date
Fri, 10.06.2022
Session Time
14:00 - 17:15
Room
MC2 HALL
Session Type
ACADEMY OF AUTOIMMUNITY

SHORT BREAK

Date
Fri, 10.06.2022
Session Time
17:15 - 17:45
Room
EXHIBITION
Session Type
BREAK
Date
Fri, 10.06.2022
Session Time
17:45 - 19:30
Room
ALEXANDRA TRIANTI
Session Type
NETWORKING EVENT
Date
Sat, 11.06.2022
Session Time
08:00 - 10:00
Room
ALEXANDRA TRIANTI
Session Type
PLENARY SESSIONS

COFFEE BREAK, EXHIBITION, POSTERS

Date
Sat, 11.06.2022
Session Time
10:00 - 10:30
Room
EXHIBITION
Session Type
BREAK
Date
Sat, 11.06.2022
Session Time
10:30 - 12:30
Room
ALEXANDRA TRIANTI
Session Type
PARALLEL SESSIONS
Date
Sat, 11.06.2022
Session Time
10:30 - 12:30
Room
NIKOS SKALKOTAS
Session Type
PARALLEL SESSIONS
Date
Sat, 11.06.2022
Session Time
10:30 - 12:30
Room
MC2 HALL
Session Type
PARALLEL SESSIONS

LUNCH BREAK, EXHIBITION, POSTERS

Date
Sat, 11.06.2022
Session Time
12:30 - 14:30
Room
EXHIBITION
Session Type
BREAK
Date
Sat, 11.06.2022
Session Time
12:45 - 14:15
Room
MC2 HALL
Session Type
INDUSTRY SUPPORTED SESSION
Session Description
Multiparametric modelling using a novel particle-based multi-analyte technology (PMAT): Shifting the dynamics of autoimmune testing - Supported by werfen

Session Description:

Autoimmune diseases are highly heterogeneous and thus require a more precise approach to medicine. Over several decades, various literature underscored the significance of autoantibodies as biomarkers aiding in the diagnosis, assessment and monitoring of disease activity, differential diagnosis of clinical manifestations, prediction of the disease course, and stratified therapy of autoimmune disease. Numerous technologies for autoantibody profiling have been developed and growing number of proof sources support the value of combining markers in improving diagnostic accuracy. Multi-analyte technologies, including the new autoantibody system called Aptiva®, show significant benefit for autoantibody profiling. Here we get a glimpse of recent clinical performance and multiparametric modelling data derived from multi-center studies on the Aptiva Connective Tissue Disease (CTD) and Celiac Disease (CD) panels. Additionally, we review the evolution and application of algorithmic analysis in discovering important biomarker signatures and their clinical utilities in autoimmunity.

Date
Sat, 11.06.2022
Session Time
14:30 - 16:30
Room
ALEXANDRA TRIANTI
Session Type
PARALLEL SESSIONS
Date
Sat, 11.06.2022
Session Time
14:30 - 16:30
Room
NIKOS SKALKOTAS
Session Type
PARALLEL SESSIONS